Current Edition

agent

Use of High-field NMR in Covid-19 Drug Development

The Covid-19 NMR Consortium, an international collaboration of NMR experts, is conducting research to determine the ribonucleic acid (RNA) structure of SARS-CoV-2 and its proteins …

Continue Reading →
COVID-19

Iconovo receives $883,800 grant from the Bill & Melinda Gates Foundation

Funding will develop inhaled therapies using ICOone Nasal in preparation for the next pandemic. Iconovo has revealed that it has received a grant of $883,800 …

Continue Reading →
Actemra/RoActemra

CHMP recommend approval for Roche’s COVID-19 therapy

According to clinical data, Roche’s new COVID-19 treatment Actemra/RoActemra lowered mortality risk in critically ill adult patients. Roche has announced the Committee for Medicinal Products …

Continue Reading →
COVID-19

JCVI responds to Omicron variant and updates its guidance

The Joint Committee on Vaccination and Immunisation (JCVI) has responded to the emergence of the Omicron variant and updated its guidance, with immediate effect. A …

Continue Reading →
COVID-19

Total UK cases of Omicron rise to nine

An additional six cases of the Omicron variant have now been detected in Scotland, bringing the UK total so far to nine. As of 26 …

Continue Reading →
breast cancer

Late cancer diagnoses rise as NHS struggles with COVID-19

Analyses provided by UK cancer charity Macmillan has provided insights into the repercussions experienced by patients waiting to receive treatment during the COVID-19 pandemic. An …

Continue Reading →
COVID-19

The Brave New World of Rapid Drug Development

The COVID-19 pandemic has brought the topic of rapid drug development to the forefront of the life sciences sector. Ray Chohan at PatSnap, believes that …

Continue Reading →
COVID-19

The New Normal: How COVID-19 Became the Catalyst for Change

When COVID-19 disrupted life sciences, solutions were needed in real-time. As the pandemic grew, so did the need to innovate. Workers met the challenges. They …

Continue Reading →
Affairs

Behavioural Science: An Untapped Opportunity for Medical Affairs

Just proving that an intervention has benefits is not always enough for it to be adopted into clinical practice. Yet in the past, pharma Medical …

Continue Reading →
Celltrion

EC approves Celltrion’s COVID-19 mAb Regkirona

The European Commission (EC) has authorised Celltrion’s COVID-19 monoclonal antibody (mAb) treatment Regkirona (regdanvimab, CT-P59), the company announced yesterday. The marketing authorisation allows for the …

Continue Reading →